Nephrocalcinosis
9
1
2
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
22%
2 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (9)
Effect of Comprehensive Spa Care on Kidney and Urological Conditions: A Clinical Study in Adult Patients
Randall's Plaque Study: Pathogenesis and Relationship to Nephrolithiasis
Multicenter, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Fluconazole in Hypercalcicuric Patients With Increased 1.25(OH) 2D Levels
Prevalence and Risk Factors of Nephrocalcinosis in Children at Sohag University Hospital
The Incidence and the Risk Factors of Nephrocalcinosis in Very Preterm Infants
Preterm Infants and Nephrocalcinosis
International Registry for Primary Hyperoxaluria
Study to Assess the Efficacy and Safety of Oral Potassium Citrate on the Prevention of Nephrocalcinosis in Extreme Premature
Alkaline Citrate Treatment to Lower the Risk of Nephrocalcinosis in Preterm Infants